ST雲維(600725.SH):預計2021年可能向金融機構申請綜合授信額度不超2億元額度
格隆匯 3 月 18日丨ST雲維(600725.SH)公佈,公司第八屆董事會第二十一次會議決議,審議通過了《關於向銀行申請2021年綜合授信額度的議案》;
公司預計2021年可能向金融機構申請綜合授信額度不超過2億元的額度,用於貿易業務中的流動資金週轉。新增2億元均為短期或中長期借款(包括但不限於流貸、票據、信用證、信託等各類型貸款)。
在新增授信額度範圍內,公司董事長根據實際融資成本和融資需要,對金融機構、額度等進行確定,公司按照財務管理的資金籌集管理相關制度規定辦理相關手續。
此議案提交公司2020年度股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.